Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
Barbara Mroczko, Magdalena Groblewska, Ala Litman‐Zawadzka
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4661-4661
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Alzheimer's disease: Recent treatment strategies
Miguel Vaz, Samuel Silvestre
European Journal of Pharmacology (2020) Vol. 887, pp. 173554-173554
Closed Access | Times Cited: 441
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10028-10028
Open Access | Times Cited: 97
Tau Oligomers Neurotoxicity
Grażyna Niewiadomska, Wiktor Niewiadomski, Marta Steczkowska, et al.
Life (2021) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 94
Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
Botond Penke, Mária Szűcs, Ferenc Bogár
Molecules (2020) Vol. 25, Iss. 7, pp. 1659-1659
Open Access | Times Cited: 88
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 74
Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Sakulrat Mankhong, Sujin Kim, Seongju Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 850-850
Open Access | Times Cited: 40
The role of short-chain fatty acids in central nervous system diseases
Yin Dong, Chun Cui
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 11, pp. 2595-2607
Closed Access | Times Cited: 40
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Julia Doroszkiewicz, Jakub Ali Farhan, Jan Mroczko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15721-15721
Open Access | Times Cited: 39
Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials
Wenting Cai, Hui Zhang, Yan Wu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access | Times Cited: 1
Cognitive resilience in Alzheimer’s disease: mechanism and potential clinical intervention
Bin Jia, Yun Xu, Xiaolei Zhu
Ageing Research Reviews (2025) Vol. 106, pp. 102711-102711
Closed Access | Times Cited: 1
Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
Hariharakrishnan Chidambaram, Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Proteotoxicity and Neurodegenerative Diseases
Clara Ruz, José Luis Alcantud, Francisco Vives Montero, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5646-5646
Open Access | Times Cited: 55
Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present)
Martina Bortolami, Daniele Rocco, Antonella Messore, et al.
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 5, pp. 399-420
Closed Access | Times Cited: 46
Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
Sanjib Guha, Sarah Fischer, Gail V.W. Johnson, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 50
GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update
Swapnil Sharma, Neha Chauhan, Swati Paliwal, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 2881-2895
Closed Access | Times Cited: 26
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1279-1279
Open Access | Times Cited: 26
Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota–gut–brain axis
Lina Ma, Xuefan Jiang, Qiao-yi Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115244-115244
Open Access | Times Cited: 15
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease
Sanjib Guha, Gail V.W. Johnson, Keith Nehrke
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5103-5120
Open Access | Times Cited: 39
Progranulin in neurodegenerative dementia
Xiaoming Wang, Peng Zeng, Ying‐Yan Fang, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 2, pp. 119-137
Open Access | Times Cited: 30
Liquid − liquid phase separation of tau: Driving forces, regulation, and biological implications
Ping Li, Jingxin Chen, Xi Wang, et al.
Neurobiology of Disease (2023) Vol. 183, pp. 106167-106167
Open Access | Times Cited: 11
Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity
Valentin Zufferey, Aatmika Barve, Enea Parietti, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
Thomas Gabriel Schreiner, Ioana Creangă-Murariu, Bogdan Ionel Tamba, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1136-1136
Open Access | Times Cited: 17
O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro
Mohammed M. Alhadidy, Paul M. Stemmer, Nicholas M. Kanaan
Journal of Biological Chemistry (2025) Vol. 301, Iss. 3, pp. 108263-108263
Closed Access
Meroterpenoids from Terrestrial and Marine Fungi: Promising Agents for Neurodegenerative Disorders—An Updated Review
Daniela S. Dimitrova, Simeonka Dimitrova, Gabriela Kehayova, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 96-96
Open Access
Page 1 - Next Page

Scroll to top